ATL releases cardiac version of HDI 3000

Article

Ultrasound vendor ATL has put the finishing touches on a cardiacversion of its high-end HDI 3000 ultrasound scanner. The systemwill be ATL's premium cardiac offering, positioned above the scannersthe Bothell, WA, firm acquired through its takeover of

Ultrasound vendor ATL has put the finishing touches on a cardiacversion of its high-end HDI 3000 ultrasound scanner. The systemwill be ATL's premium cardiac offering, positioned above the scannersthe Bothell, WA, firm acquired through its takeover of Interspeclast year.

To optimize HDI 3000 for cardiac imaging, ATL added cardiac protocolsto the system's tissue specific imaging (TSI) feature, which providesusers with a series of predetermined settings that optimize thescanner's parameters for the type of exam being conducted. ATLalso refined other cardiac-specific functions on HDI 3000, suchas EKG. The probes required for cardiac imaging are already onthe market.

ATL also has refined its Color Power Angio power Doppler techniquefor cardiac applications. Rather than focus on blood flow andminute vessels as power Doppler techniques do, Power Motion Imagingshows heart wall motion.

In other ATL news, the company said it expects to post resultsfor the second quarter of 1995 that meet analysts' predictionsranging from a loss of 2¢ a share to a profit of 8¢,according to Dow Jones News Service.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.